Davol Market Share Analysis for November 2025

for more than a century. c. r. bard, inc. has pioneered the development and manufacture of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties.

Health > Health - Other

Domaindavol.com

Year Founded1874

Employees501 - 1000

Annual Revenue$50M - $75M

Davol

Davol (including company regionals)

davol.com

See more website traffic and engagement information

Davol Revenue up to November 2025 is 50M - 75M

revenue generated by Davol top domains

Davol top domains revenue over 3 years

Revenue for Davol top domains

davol.com50M - 75M

See more with Sales Intelligence

Total visits to Davol's top domains

Understand Davol market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Davol's top domains

Analyze Davol engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Davol's top domains

See how Davol keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Davol top competitors by domain

Top similar sites in November 2025, ranked by their affinity

covidien.comCompany NameCovidienEmployees> 10001HQUnited States, Massachusetts, MansfieldAnnual revenue> $1BTotal visits--Health > Health - Other

Top technologies used by Davol

These are the website technologies, by industry, used by Davol top domains

Widget (3)

reCAPTCHA

Audio Video Media (2)

YouTube

Conversion & Analytics (2)

Google Analytics

Marketing (2)

Google Marketing Platform

More Technologies

8

See all

News & Signals from Davol

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDavol Inc. has issues with recall of specific lots.Davol is expanding the voluntary recall of specific lots of Bard® Composix® Kugel® Large Oval and Large Circle Patches.